Skip to main content
SpringerLink
Log in
Book cover

Mechanische Unterstützung im akuten Kreislaufversagen pp 61–73Cite as

Kardiologische Systeme

  • Chapter
  • First Online:

  • 2530 Accesses

Zusammenfassung

Die Mortalität im kardiogenen Schock verbleibt weiterhin im Bereich von 50 % trotz lebensrettender Maßnahmen, wie der frühen Revaskularisierung und des Einsatzes der intraaortalen Gegenpulsation, für die in prospektiven Studien keine Wirksamkeit belegt werden konnte (Aissaoui et al. 2012). Unabhängig von der weiterhin ungünstigen Prognose des kardiogenen Schocks hat sich im Wandel der Zeit die Population des kardiogenen Schocks verändert: Während zur Zeit des Landmark SHOCK Trials überwiegend ST-Hebungsinfarkte die Ursache für einen kardiogenen Schock repräsentierten (Hochman et al. 1999), so wuchs im Laufe der Jahre, auch infolge der Therapieerfolge bei der initialen Infarktbehandlung, die Gruppe der Patienten, bei denen der kardiogene Schock das Ende der Herzinsuffizienzspirale im Sinne einer akuten Dekompensation bei chronischer Herzinsuffizienz darstellt.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   59.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   74.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Literatur

  • Aissaoui N, Puymirat E, Tabone X, Charbonnier B, Schiele F, Lefevre T et al (2012) Improved outcome of cardiogenic shock at the acute stage of myocardial infarction: a report from the USIK 1995, USIC 2000, and FAST-MI French nationwide registries. Eur Heart J 33(20):2535–2543

    Article  Google Scholar 

  • Anderson MB, Goldstein J, Milano C, Morris LD, Kormos RL, Bhama J et al (2015) Benefits of a novel percutaneous ventricular assist device for right heart failure: the prospective RECOVER RIGHT study of the Impella RP device. J Heart Lung Transplant 34(12):1549–1560

    Article  Google Scholar 

  • Bauersachs J, Arrigo M, Hilfiker-Kleiner D, Veltmann C, Coats AJ, Crespo-Leiro MG et al (2016) Current management of patients with severe acute peripartum cardiomyopathy: practical guidance from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy. Eur J Heart Fail 18:1096–1105

    Article  Google Scholar 

  • Cheng R, Hachamovitch R, Kittleson M, Patel J, Arabia F, Moriguchi J et al (2014) Complications of extracorporeal membrane oxygenation for treatment of cardiogenic shock and cardiac arrest: a meta-analysis of 1,866 adult patients. Ann Thorac Surg 97(2):610–616

    Article  Google Scholar 

  • Engstrom AE, Cocchieri R, Driessen AH, Sjauw KD, Vis MM, Baan J et al (2011) The Impella 2.5 and 5.0 devices for ST-elevation myocardial infarction patients presenting with severe and profound cardiogenic shock: the academic medical center intensive care unit experience. Crit Care Med 39(9):2072–2079

    Article  Google Scholar 

  • Ezekowitz JA, Kaul P, Bakal JA, Armstrong PW, Welsh RC, McAlister FA (2009) Declining in-hospital mortality and increasing heart failure incidence in elderly patients with first myocardial infarction. J Am Coll Cardiol 53(1):13–20

    Article  Google Scholar 

  • Ghio S, Gavazzi A, Campana C, Inserra C, Klersy C, Sebastiani R et al (2001) Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure. J Am Coll Cardiol 37(1):183–188

    Article  CAS  Google Scholar 

  • Hochman JS, Sleeper LA, Webb JG, Sanborn TA, White HD, Talley JD et al (1999) Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK investigators. Should we emergently revascularize occluded coronaries for cardiogenic shock. N Engl J Med 341(9):625–634

    Article  CAS  Google Scholar 

  • Horn P, Saeed D, Akhyari P, Hilfiker-Kleiner D, Kelm M, Westenfeld R (2017) Complete recovery of fulminant peripartum cardiomyopathy on mechanical circulatory support combined with high-dose bromocriptine therapy. ESC Heart Fail. 4:641–644

    Article  Google Scholar 

  • Jacobs AK, Leopold JA, Bates E, Mendes LA, Sleeper LA, White H et al (2003) Cardiogenic shock caused by right ventricular infarction: a report from the SHOCK registry. J Am Coll Cardiol 41(8):1273–1279

    Article  Google Scholar 

  • Kapur NK, Paruchuri V, Jagannathan A, Steinberg D, Chakrabarti AK, Pinto D et al (2013) Mechanical circulatory support for right ventricular failure. JACC Heart Fail 1(2):127–134

    Article  Google Scholar 

  • Kapur NK, Paruchuri V, Pham DT, Reyelt L, Murphy B, Beale C et al (2015) Hemodynamic effects of left atrial or left ventricular cannulation for acute circulatory support in a bovine model of left heart injury. ASAIO J 61(3):301–306

    Article  Google Scholar 

  • Kapur NK, Alkhouli MA, DeMartini TJ, Faraz H, George ZH, Goodwin MJ et al (2019) Unloading the left ventricle before reperfusion in patients with Anterior ST-Segment-Elevation Myocardial Infarction. Circulation 139(3):337–346

    Article  Google Scholar 

  • Kormos RL, Teuteberg JJ, Pagani FD, Russell SD, John R, Miller LW et al (2010) Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on out-comes. J Thorac Cardiovasc Surg 139(5):1316–1324

    Article  Google Scholar 

  • Kuchibhotla S, Esposito ML, Breton C, Pedicini R, Mullin A, O’Kelly R et al (2017) Acute biventricular mechanical circulatory support for cardiogenic shock. J Am Heart Assoc. 6(10):pii: e006670

    Article  Google Scholar 

  • Lauten A, Engstrom AE, Jung C, Empen K, Erne P, Cook S et al (2013) Percutaneous left-ventricular support with the Impella-2.5-assist device in acute cardiogenic shock: results of the Impella-EUROSHOCK-registry. Circ Heart Fail 6(1):23–30

    Article  Google Scholar 

  • Mehra MR, Goldstein DJ, Uriel N, Cleveland JC Jr, Yuzefpolskaya M, Salerno C et al (2018) Two-year outcomes with a magnetically levitated cardiac pump in heart failure. N Engl J Med 378(15):1386–1395

    Article  Google Scholar 

  • O’Neill WW, Kleiman NS, Moses J, Henriques JP, Dixon s, Massaro J et al (2012) A prospective, randomized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention: the PROTECT II study. Circulation 126(14):1717–1727

    Article  Google Scholar 

  • Ouweneel DM, Eriksen E, Sjauw KD, van Dongen IM, Hirsch A, Packer EJ et al (2017) Impella CP versus intra-aortic balloon pump support in acute myocardial infarction complicated by cardiogenic shock. The IMPRESS in Severe Shock trial. J Am Coll Card 69:278–287

    Article  Google Scholar 

  • Ramanathan K, Farkouh ME, Cosmi JE, French JK, Harkness SM, Dzavik V et al (2011) Rapid complete reversal of systemic hypoperfusion after intra-aortic balloon pump counterpulsation and survival in cardiogenic shock complicating an acute myocardial infarction. Am Heart J 162(2):268–275

    Article  Google Scholar 

  • Rihal CS, Naidu SS, Givertz MM, Szeto WY, Burke JA, Kapur NK et al (2015) SCAI/ACC/HFSA/STS clinical expert consensus statement on the use of percutaneous mechanical circulatory support devices in cardiovascular care. J Card Fail 21:499–518

    Article  Google Scholar 

  • Rogers JG, O’Connor CM (2014) The changing landscape of advanced heart failure therapeutics. J Am Coll Cardiol 64(14):1416–1417

    Article  Google Scholar 

  • Schäfer A, Werner N, Westenfeld R, Møller JE, Schulze PC, Karatolios K et al (2019) Clinical scenarios for use of transvalvular microaxial pumps in acute heart failure and cardiogenic shock – a European experienced users working group opinion. Int J Cardiol 15(291):96–104

    Article  Google Scholar 

  • Schrage B, Ibrahim K, Loehn T, Werner N, Sinning J-M, Pappalardo F et al (2019) Impella support for acute myocardial infarction complicated by cardiogenic shock: a matched-pair IABP- SHOCK II trial 30-day mortality analysis. Circulation 139:1249–1258

    Article  Google Scholar 

  • Seyfarth M, Sibbing D, Bauer I, Frohlich G, Bott-Flugel L, Byrne R et al (2008) A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. J Am Coll Cardiol 52(19):1584–1588

    Article  Google Scholar 

  • Sundaravel S, Alrifai A, Kabach M, Ghumman W (2017) FOLFOX induced Takotsubo cardiomyopathy treated with Impella assist device. Case Rep Cardiol 2017:8507096

    PubMed  PubMed Central  Google Scholar 

  • Thiele H, Sick P, Boudriot E, Diederich KW, Hambrecht R, Niebauer J et al (2005) Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock. Eur Heart J 26(13):1276–1283

    Article  Google Scholar 

  • Thiele H, Allam B, Chatellier G, Schuler G, Lafont A (2010) Shock in acute myocardial infarction: the Cape Horn for trials? Eur Heart J 31:1828–1835

    Article  Google Scholar 

  • Thiele H, Zeymer U, Neumann FJ, Ferenc M, Olbrich HG, Hausleiter J et al (2012) Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med 367(14):1287–1296

    Article  CAS  Google Scholar 

  • Wayangankar SA, Bangalore S, McCoy LA, Jneid H, Latif F, Karrowni W et al (2016) Temporal trends and outcomes of patients undergoing percutaneous coronary interventions for cardiogenic shock in the setting of acute myocardial infarction: a report from the CathPCI registry. JACC Cardiovasc Interv 9:341–351

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. UK Düsseldorf, Düsseldorf, Deutschland

    Ralf Westenfeld

Authors
  1. Ralf Westenfeld
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ralf Westenfeld .

Editor information

Editors and Affiliations

  1. Klinik für Herzchirurgie, Universitätsklinikum Düsseldorf, Düsseldorf, Germany

    Udo Boeken

  2. Klinik für Herzchirurgie, Universitätsklinikum Düsseldorf, Düsseldorf, Germany

    Alexander Assmann

  3. Klinik für Herzchirurgie und Gefäßchirurgie, Segeberger Kliniken GmbH, Bad Segeberg, Germany

    Stefan Klotz

  4. Herzchirurgische Klinik und Poliklinik, Klinikum der Universität München, München, Germany

    Frank Born

  5. Kardiologie, Kerckhoff-Klinik GmbH, Bad Nauheim, Germany

    Andreas Rieth

  6. Klinik für Herz-, Thorax- und herznahe Gefäßchirurgie, Universitätsklinikum Regensburg, Regensburg, Germany

    Christof Schmid

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Westenfeld, R. (2020). Kardiologische Systeme. In: Boeken, U., Assmann, A., Klotz, S., Born, F., Rieth, A., Schmid, C. (eds) Mechanische Unterstützung im akuten Kreislaufversagen. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-59901-3_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-59901-3_5

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-59900-6

  • Online ISBN: 978-3-662-59901-3

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation